![Ann MacDougall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ann MacDougall
Directeur/Membre du Conseil chez
ALOPEXX, INC.
Profil
Ann MacDougall is currently an Independent Director at Alopexx, Inc., a Director at Atmos Xr since 2017, and a Director at Strongminds Zambia.
Former roles include Chairman at Progenics Pharmaceuticals, Inc. from 2019 to 2020, Independent Director at Opiant Pharmaceuticals, Inc. from 2016 to 2023, General Counsel at PricewaterhouseCoopers LLP from 1994 to 2007, Principal at US West, Inc., Chief Administrative Officer at Acumen Fund, Inc., President at Encore.
Org from 2014 to 2017, and a position at Coopers & Lybrand LLP in 2004.
Education includes undergraduate studies at Tufts University and graduate studies at Brooklyn Law School.
Postes actifs de Ann MacDougall
| Sociétés | Poste | Début |
|---|---|---|
| ALOPEXX, INC. | Directeur/Membre du Conseil | - |
Atmos Xr | Directeur/Membre du Conseil | 01/10/2017 |
Strongminds Zambia | Directeur/Membre du Conseil | - |
Anciens postes connus de Ann MacDougall
| Sociétés | Poste | Fin |
|---|---|---|
| OPIANT PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 02/03/2023 |
| PROGENICS PHARMACEUTICALS, INC. | Président | 19/06/2020 |
Encore.Org | President | 01/10/2017 |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Comptroller/Controller/Auditor | 01/01/2007 |
US West, Inc.
 US West, Inc. Major TelecommunicationsCommunications Engages in telecommunications services | Corporate Officer/Principal | - |
Formation de Ann MacDougall
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
90
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for prostate cancer | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops medicines for addictions and drug overdose | Health Technology |
US West, Inc.
US West, Inc. Major TelecommunicationsCommunications Engages in telecommunications services | Communications |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brooklyn Law School
 Brooklyn Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acumen Fund, Inc.
 Acumen Fund, Inc. Investment ManagersFinance Acumen Fund invests in companies located across the globe. The firm focuses on a broad range of sectors. It provides equity and debt financing for seed and early-stage transactions. | Finance |
Encore.Org | |
Alopexx, Inc.
 Alopexx, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company which develops novel and broad-spectrum immune-mediated therapeutics | Health Technology |
Atmos Xr | |
Strongminds Zambia |
